In nonalcoholic steatohepatitis, limiting ADAM17 activity increases MerTK expression in macrophages, which further induces TGF-β1 production, leading to the activation of hepatic stellate cells by TGF-β1 to encourage liver fibrosis [63]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.